Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
SPDR S&P 500 ETF Trust slipped 0.9% in pre-market trade to $765.92 amid a broad retreat from risk assets driven by disappointing technology results, a jump in global oil prices and sustained high long-term yields. Weakness in semiconductor-related names, fresh attacks in Saudi Arabia pushing oil higher, and an elevated 10-year Treasury yield combin…
Travala and the AVA Foundation have introduced the AVA Buyback Multiplier, a tiered system that increases Travala’s monthly matched buyback of AVA tokens in proportion to the AVA rewards earned by AVA Smart members. The change scales Travala’s match from 1x up to 3x depending on the previous month’s givebacks, taking combined monthly buybacks to as…
Apple (AAPL) is a buy for disciplined portfolios at current levels thanks to $136.7B in free cash flow, a $5.03T market cap, and steady services and hardware cash generation. Valuation is rich (PE ~39, PB ~46.7, EV/EBITDA ~30), so we recommend a tactical long with strict sizing (3% portfolio) and a mid-term horizon to capture post-product-cycle and…
Arbutus Biopharma shares rose in pre-market trading after the FDA removed the clinical hold on the company's IND for AB-101, an oral PD-L1 inhibitor for chronic HBV. The decision, filed in a Form 8-K, allows further U.S. clinical development following Phase 1a/1b data showing tolerability and high receptor occupancy. Institutional buying and a rece…
MSCI reported 12.4% revenue growth and beat Q3 estimates, but the shares are priced for perfection. With a market cap near $44B, P/E ~31, EV/EBITDA ~24 and FCF yield around 3.3%, upside is limited versus the downside to a re-rating if growth or margin tailwinds slow. I outline a mid-term short trade (45 trading days) with an entry at $604.71, a $66…
Cuba's transportation system has contracted to historic lows following a de facto U.S. ban on fuel imports, the country's Transportation Minister says. Passenger trips on public transport are forecast to fall sharply, bus services have been slashed, and domestic freight volumes are set to plunge, prompting a rapid pivot to electric vehicles that is…
Rigel is morphing from a small clinical-stage biotech into a commercial biotech with multiple near-term revenue drivers. FDA approval and a global licensing deal for VEPPANU, steady rollouts of TAVALISSE in Latin America, and recent revenue beats make a compelling case for a re-rate. The balance sheet, cash flow and cheap valuation (sub-3x reported…
Workiva is executing on margin expansion and organic growth at scale: record operating margins, accelerating revenue (~20% year-over-year), and $200M+ of free cash flow. The stock is still trading below historical multiples. This trade targets a re-rate to a more normalized SaaS multiple as AI adoption and enterprise spend lift ARR trajectory.
Meta's Q3 beat and early Muse traction (10M North American users) mark a structural shift: advertising strength is being complemented by a first meaningful AI revenue engine. Valuation sits at a reasonable multiple given growth and $41B in free cash flow. This trade idea buys a pullback into strength with a long-term horizon and defined stop.
Bybit Kazakhstan and the Alatau City Authority signed a non-binding Memorandum of Cooperation at the AI & Digital Bridge 2026 forum in Astana, outlining collaboration on tokenization of real-world assets, digital asset payment systems, and cross-border remittance solutions as Alatau City evolves under its special legal regime.
Tenet Healthcare (THC) is showing clearer margin improvement and cash conversion than many expect. With EV/EBITDA at 6.85, P/E near 9.7, and free cash flow roughly $3.0B, the stock can re-rate if Q3 results on 10/29/2026 confirm accelerating operating leverage. This trade targets a measured long into and after the print with tight risk control.
Teledyne's mix of high-margin sensors, aerospace electronics and engineered systems is hitting a sweet spot: strong defense infrared demand, a record $5.3B funded backlog and improving margin dynamics are supporting revenue upgrades. With a $29.2B market cap, healthy cash flow ($1.14B FCF) and modest leverage (debt/equity 0.19), this is an actionab…
Texas Instruments has reported another set of upside results and is showing signs of a broader recovery in its end markets. With free cash flow of $5.36B, a 2% dividend yield, and management signaling a quieter capex profile, the risk/reward looks favorable for a mid-term long trade. Technicals are mixed but improving; valuation is premium, so posi…
The U.S. dollar slipped to near a three-week low on Thursday as a drop in global bond yields and turbulence in AI-linked tech stocks and corporate debt prompted reallocations into duration and non-dollar currencies. The Japanese yen outperformed peers, pushing USD/JPY below its 50-day moving average, while the euro and Australian dollar showed mixe…
Diageo is positioned to benefit from renewed alcohol demand among younger drinkers and the global ready-to-drink cocktail trend. Technicals and consumption signals support a tactical long with a clear entry, stop and target over a 180 trading-day horizon.
Privia Health (PRVA) has been compounding top-line growth while beginning to show meaningful EBITDA and free cash flow leverage. With a $2.87B market cap, low/no net debt, and improving operating metrics, the stock looks set up for a mid-term swing trade. Entry $22.50, target $27.50, stop $20.50.
European wholesale gas prices climbed further on Thursday, driven by a wave of Houthi attacks in Saudi Arabia that prompted the U.S. State Department to order evacuations of non-emergency personnel and families. Benchmark Dutch and British contracts rose about 1%, while Brent crude held near five-month highs. Concerns about rerouted LNG shipments a…
UnitedHealth reported Q3 strength with revenue of $113B and an upgraded EPS outlook; improving Optum margins, sizable free cash flow, and ongoing AI-driven efficiency gains support further multiple expansion. Trade plan: enter at $419.00, target $480.00, stop $390.00 over a 180 trading day horizon.
GoGold (GLGDF) trades at $2.70 with a $1.17B market cap, underpinned by producing Parral tailings and the Los Ricos exploration pipeline. If management delivers the expected production ramp into 2028, the stock can re-rate materially. This trade idea sets an entry at $2.70, a $5.40 target and a $2.00 stop for a long-term (180 trading days) position…
Evolution Petroleum (EPM) pays a quarterly $0.12 dividend (12.8% yield at current price). Recent acquisitions, modest leverage and an EV/EBITDA of 7.7 give the company a credible path to sustain payouts into FY2027, even though earnings and free cash flow are pressured. This trade targets capital appreciation to $5.20 while preserving the dividend …
Houlihan Lokey (HLI) is one of the few boutique advisory firms built to benefit from an uptick in distressed situations. With Financial Restructuring as a core segment, solid free cash flow and a reasonable valuation, HLI offers asymmetric upside if defaults and private-credit stress continue. This trade plan outlines an entry at $128.39, a stop at…
Semtech's recent prints and guidance point to a meaningful acceleration in data-center connectivity revenue after a period of digestion. The market is pricing a stretched multiple on slower growth; we think current momentum and share gains in 800G / 1.6T copper and fiber products justify a re-rating. This is a swing trade with a clear entry, stop, …
Kingstone (KINS) is a small, profitable regional P&C insurer trading at a modest multiple. Management’s move toward retaining more risk (less reinsurance) should lift near-term earnings and free cash flow, but also raises reserve and catastrophe exposure. Trade plan presented for a mid-term swing capturing earnings leverage while protecting against…
BlackBerry's QNX division is transitioning from design wins to royalty-bearing production programs. Recent wins (Coretura/Alloy Kore) add meaningful backlog and validate the firm's strategy to capture more software value per vehicle. With improving cash flow, upgraded guidance, and a still-fragile Secure Communications line, this trade seeks to buy…
Broadcom's playbook of tuck-ins and large-scale acquisitions has historically unlocked outsized cash-flow expansion and margin improvement. With a market cap near $1.61T, free cash flow of roughly $39.4B and a P/E around 42.7x, the current pullback versus its $495 52-week peak creates an entry where a fresh M&A announcement or faster integration co…
